- Report
- July 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,509GBP
- Report
- April 2026
- 115 Pages
Global
From €4366EUR$4,750USD£3,712GBP
- Report
- August 2026
- 160 Pages
Global
From €3052EUR$3,320USD£2,595GBP
€3815EUR$4,150USD£3,243GBP
- Report
- May 2026
- 150 Pages
United States
From €2564EUR$2,789USD£2,180GBP
- Report
- May 2025
- 210 Pages
Global
From €2298EUR$2,500USD£1,954GBP
- Report
- July 2025
- 186 Pages
Global
From €4137EUR$4,500USD£3,517GBP
- Report
- January 2024
- 150 Pages
Global
From €4458EUR$4,850USD£3,790GBP
- Report
- August 2023
- 94 Pages
Global
From €3500EUR$4,079USD£3,080GBP
- Report
- March 2024
- 132 Pages
Global
From €873EUR$950USD£742GBP
The IUCD (intrauterine contraceptive device) market is a subset of the medical device industry. IUCDs are small, T-shaped devices that are inserted into the uterus to prevent pregnancy. They are a long-acting, reversible form of contraception that can be used for up to five years. IUCDs are a popular choice for women who want a reliable form of contraception without the need for daily or weekly maintenance.
The IUCD market is highly competitive, with a range of products available from different manufacturers. The market is dominated by a few large players, such as Bayer, Merck, and Teva Pharmaceuticals. Other companies in the market include CooperSurgical, Hologic, and Allergan. Show Less Read more
